Literature DB >> 22636321

IFN-γ-deficient mice develop IL-1-dependent cutaneous and musculoskeletal inflammation during experimental brucellosis.

Jerod A Skyberg1, Theresa Thornburg, Irina Kochetkova, William Layton, Gayle Callis, MaryClare F Rollins, Carol Riccardi, Todd Becker, Sarah Golden, David W Pascual.   

Abstract

Human brucellosis exhibits diverse pathological manifestations that can affect almost any organ. In particular, osteoarticular complications are the most common focal manifestation of brucellosis and occur in 40-80% of patients. In immunocompetent mice, Brucella replication is generally restricted to the spleen, liver, and to a lesser extent, LNs, thereby limiting their use for study of focal inflammation often found in brucellosis. Here, we report that nasal, oral, or peritoneal infection of IFN-γ(-/-) mice with WT Brucella melitensis or Brucella abortus results in joint and periarticular tissue inflammation. Histological analysis of the affected joints revealed inflammatory infiltrates and debris within the joint space colocalizing with Brucella antigen. Osteoarthritis, necrosis, periarticular soft tissue inflammation, and substantial brucellae burdens were observed. Oral rifampicin was effective in clearing infection and halting further progression of focal inflammation from infected IFN-γ(-/-) mice, although some symptoms and swelling remained. Elevated IL-1 β, but not TNF-α, IL-6, or IL-17, was detected in joint homogenates from infected IFN-γ(-/-) mice. Whereas more susceptible to systemic infection, IL-1R(-/-) mice depleted of IFN-γ were more resistant to focal inflammation than WT mice similarly depleted of IFN-γ. Collectively, these results show IFN-γ(-/-) mice represent a potential model for study of focal inflammation attributed to Brucella infection and will allow evaluation of intervention strategies targeting IL-1, IL-1R, or other inflammatory mediators, with the potential to complement antibiotic-based therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22636321      PMCID: PMC3395417          DOI: 10.1189/jlb.1211626

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  78 in total

1.  Septic arthritis caused by Rothia dentocariosa in a patient with rheumatoid arthritis receiving etanercept therapy.

Authors:  Marta Favero; Bernd Raffeiner; Diego Cecchin; Franco Schiavon
Journal:  J Rheumatol       Date:  2009-12       Impact factor: 4.666

2.  Therapeutic effect of (Z)-3-(2,5-dimethoxyphenyl)-2-(4-methoxyphenyl) acrylonitrile (DMMA) against Staphylococcus aureus infection in a murine model.

Authors:  Ki-Bong Oh; Kung-Woo Nam; Hyunjin Ahn; Jongheon Shin; Sanghee Kim; Woongchon Mar
Journal:  Biochem Biophys Res Commun       Date:  2010-04-28       Impact factor: 3.575

3.  IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10.

Authors:  Irina Kochetkova; Sarah Golden; Kathryn Holderness; Gayle Callis; David W Pascual
Journal:  J Immunol       Date:  2010-05-10       Impact factor: 5.422

4.  Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.

Authors:  Beata Clapp; Jerod A Skyberg; Xinghong Yang; Theresa Thornburg; Nancy Walters; David W Pascual
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

5.  Interferon-gamma low producer genotype +5644 over presented in patients with focal brucellosis.

Authors:  A Hedayatizadeh-Omran; A Rafiei; M Hajilooi; M Haghshenas
Journal:  Pak J Biol Sci       Date:  2010-11-01

6.  Interleukin-1 receptor-associated kinase 4 is essential for initial host control of Brucella abortus infection.

Authors:  Fernanda S Oliveira; Natália B Carvalho; Ana Paula M S Brandão; Marco Túlio R Gomes; Leonardo A de Almeida; Sérgio C Oliveira
Journal:  Infect Immun       Date:  2011-08-15       Impact factor: 3.441

7.  Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen.

Authors:  Tatiane A Paixão; Christelle M Roux; Andreas B den Hartigh; Sumathi Sankaran-Walters; Satya Dandekar; Renato L Santos; Renée M Tsolis
Journal:  Infect Immun       Date:  2009-08-03       Impact factor: 3.441

8.  Inflammasome sensor Nlrp1b-dependent resistance to anthrax is mediated by caspase-1, IL-1 signaling and neutrophil recruitment.

Authors:  Mahtab Moayeri; Devorah Crown; Zachary L Newman; Shu Okugawa; Michael Eckhaus; Christophe Cataisson; Shihui Liu; Inka Sastalla; Stephen H Leppla
Journal:  PLoS Pathog       Date:  2010-12-09       Impact factor: 6.823

9.  Murine and bovine γδ T cells enhance innate immunity against Brucella abortus infections.

Authors:  Jerod A Skyberg; Theresa Thornburg; Maryclare Rollins; Eduardo Huarte; Mark A Jutila; David W Pascual
Journal:  PLoS One       Date:  2011-07-12       Impact factor: 3.240

10.  A case of tuberculous arthritis following the use of etanercept.

Authors:  Seung Won Choi; Jong Joon Ahn; Young Tae Hwang; Sang Hoon Koh; Sung Do Cho
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 2.884

View more
  15 in total

1.  The NOD-scid IL2rγnull Mouse Model Is Suitable for the Study of Osteoarticular Brucellosis and Vaccine Safety.

Authors:  Omar H Khalaf; Sankar P Chaki; Daniel G Garcia-Gonzalez; Thomas A Ficht; Angela M Arenas-Gamboa
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

2.  IFN-γ-dependent nitric oxide suppresses Brucella-induced arthritis by inhibition of inflammasome activation.

Authors:  Carolyn A Lacey; Catherine A Chambers; William J Mitchell; Jerod A Skyberg
Journal:  J Leukoc Biol       Date:  2019-02-12       Impact factor: 4.962

3.  B Cells Inhibit CD4+ T Cell-Mediated Immunity to Brucella Infection in a Major Histocompatibility Complex Class II-Dependent Manner.

Authors:  Alexis S Dadelahi; Carolyn A Lacey; Catherine A Chambers; Bárbara Ponzilacqua-Silva; Jerod A Skyberg
Journal:  Infect Immun       Date:  2020-04-20       Impact factor: 3.441

4.  Temporal Role for MyD88 in a Model of Brucella-Induced Arthritis and Musculoskeletal Inflammation.

Authors:  Carolyn A Lacey; William J Mitchell; Charles R Brown; Jerod A Skyberg
Journal:  Infect Immun       Date:  2017-02-23       Impact factor: 3.441

5.  Caspase-1 and Caspase-11 Mediate Pyroptosis, Inflammation, and Control of Brucella Joint Infection.

Authors:  Carolyn A Lacey; William J Mitchell; Alexis S Dadelahi; Jerod A Skyberg
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

6.  Interaction of Brucella abortus with Osteoclasts: a Step toward Understanding Osteoarticular Brucellosis and Vaccine Safety.

Authors:  Omar H Khalaf; Sankar P Chaki; Daniel G Garcia-Gonzalez; Larry J Suva; Dana Gaddy; Angela M Arenas-Gamboa
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

Review 7.  Alternative strategies for vaccination to brucellosis.

Authors:  David W Pascual; Xinghong Yang; Hongbin Wang; Zakia Goodwin; Carol Hoffman; Beata Clapp
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

8.  CXCR2 Mediates Brucella-Induced Arthritis in Interferon γ-Deficient Mice.

Authors:  Carolyn A Lacey; Lauren L Keleher; William J Mitchell; Charles R Brown; Jerod A Skyberg
Journal:  J Infect Dis       Date:  2016-03-06       Impact factor: 5.226

9.  Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.

Authors:  Jerod A Skyberg; Maryclare F Rollins; Joshua W Samuel; Marjorie D Sutherland; John T Belisle; David W Pascual
Journal:  Infect Immun       Date:  2013-06-17       Impact factor: 3.441

10.  MyD88-Dependent Glucose Restriction and Itaconate Production Control Brucella Infection.

Authors:  Carolyn A Lacey; Bárbara Ponzilacqua-Silva; Catherine A Chambers; Alexis S Dadelahi; Jerod A Skyberg
Journal:  Infect Immun       Date:  2021-06-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.